FDA Adds 37 Chinese Food Packaging Firms to Import Alert

On May 6, 2026, the U.S. Food and Drug Administration (FDA) updated Import Alert 99-05, placing 37 Chinese food packaging suppliers on automatic detention due to missing FSMA compliance statements and food contact material migration test reports. Exporters of paper-plastic composite food containers, vacuum pouches, and label substrates destined for the U.S., Canada, and Mexico are now facing port rejections and shipment delays averaging 12–18 days — a development with immediate implications for food packaging exporters, converters, and global supply chain stakeholders.

Event Overview

The U.S. FDA issued an update to Import Alert 99-05 on May 6, 2026, adding 37 China-based food packaging manufacturers to its list of firms subject to automatic detention. The stated reason is non-compliance with 21 CFR Parts 110 and 117, specifically the failure to submit required FSMA compliance declarations and migration testing reports for food contact materials. As confirmed by publicly available FDA records, multiple shipments—including paper-plastic composite meal trays, vacuum-seal bags, and label base materials—have been detained at U.S. ports of entry since the alert took effect.

Industries Affected

Direct Exporters (U.S.-bound Food Packaging Suppliers)

These firms face immediate shipment rejection unless they resolve documentation gaps. Automatic detention triggers mandatory FDA review of each consignment, eliminating routine clearance and extending customs processing time significantly.

Raw Material Suppliers (e.g., Paper, Plastic Film, Adhesive Producers)

Although not directly named in the alert, upstream suppliers may experience downstream pressure to provide certified migration data or revised declarations — especially when their materials are incorporated into finished packaging cited in the alert.

Contract Converters & Co-packers

Firms that print, laminate, or assemble packaging for branded clients are affected if their facility-level compliance documentation (e.g., preventive controls plans, supplier verification records) is incomplete or misaligned with FDA expectations for finished food contact articles.

Distribution & Logistics Providers Serving North America

Freight forwarders and customs brokers handling food packaging shipments must now verify FSMA-related documentation pre-arrival. Delays in document submission or discrepancies between declared and actual product specifications increase the risk of hold-and-review outcomes.

Key Points for Enterprises and Practitioners to Monitor and Act On

Track official FDA communications and alert revisions

Import Alert 99-05 remains active and subject to further updates. Firms should monitor FDA’s Import Alerts database regularly, particularly for changes in listed firms, scope expansions (e.g., added product categories), or new documentation requirements referenced in related guidance documents.

Verify documentation status for high-risk product categories

Based on the current alert, paper-plastic composites, vacuum pouches, and pressure-sensitive label substrates require special attention. Exporters should confirm whether their specific formulations have undergone migration testing per FDA-recommended protocols (e.g., FDA CPG 7117.05, ISO 10993-12) and whether declarations reflect accurate facility-level FSMA compliance.

Distinguish between regulatory signal and operational impact

This action reflects enforcement of existing requirements — not introduction of new rules. Analysis shows the FDA is applying long-standing provisions under FSMA’s Foreign Supplier Verification Program (FSVP) and Current Good Manufacturing Practice (cGMP) regulations more rigorously at the point of entry. It does not indicate a broader policy shift, but rather intensified targeting of persistent documentation gaps.

Prepare documentation packages ahead of shipment scheduling

Enterprises should compile and pre-validate all required documentation — including signed FSMA compliance statements, third-party migration test reports, and supplier verification records — before initiating production or booking freight. This reduces last-minute delays and supports faster resolution if a shipment is flagged.

Editorial Perspective / Industry Observation

Observably, this alert functions less as a one-off enforcement action and more as a calibrated signal to Chinese food packaging exporters: documentation completeness — not just product safety — is now a decisive factor in U.S. market access. From an industry perspective, the 12–18 day average delay reflects systemic friction, not isolated incidents; it suggests recurring bottlenecks in how compliance evidence is generated, translated, and submitted across language and regulatory frameworks. Current enforcement appears focused on verifiability — i.e., whether evidence meets FDA’s evidentiary standards — rather than novelty of requirement. That makes sustained attention to documentation hygiene, not just technical compliance, the priority for affected firms.

Conclusion: This FDA action underscores that import eligibility for food packaging into the U.S. market hinges increasingly on procedural rigor — particularly consistent, traceable, and regulator-ready documentation. It is best understood not as an escalation in regulatory burden, but as a reinforcement of existing obligations under FSMA. For stakeholders, the most constructive response is systematic documentation readiness — aligned with FDA’s evidentiary expectations — rather than reactive crisis management.

Source: U.S. FDA Import Alert 99-05 (updated May 6, 2026); FDA public enforcement database. Note: Ongoing monitoring is recommended for potential additions to the alert list or clarifications in FDA guidance documents related to food contact substance submissions.